IL18 and diffuse large B-cell lymphoma: In the DLBCL study of Lu et al., pSTAT3 protein levels decreased after IL-18 and NLPR3 inflammasome inhibition, possibly linking it to the observed concomitant PD-L1 downregulation [86].